Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra in Recently Decompensated Systolic Heart Failure
NCT03797001Phase 2Completed
- Sponsor
- Virginia Commonwealth University
- Start
- Jan 2019
- Primary completion
- Jul 2024
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial comparing Anakinra Arm with Placebo Arm (2 arms). Primary endpoint: Peak Oxygen Consumption at 24 weeks. Started Jan 2019; status: completed.
02
Drugs
anakinra
Beyond the preview
Go deeper on NCT03797001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03797001.